HomeENSC • NASDAQ
add
Ensysce Biosciences Inc
Previous close
$2.03
Day range
$1.81 - $2.11
Year range
$1.70 - $14.67
Market cap
3.22M USD
Avg Volume
41.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.30M | 153.12% |
Operating expense | 1.08M | -25.07% |
Net income | -3.56M | -1.74% |
Net profit margin | -273.42 | 59.80% |
Earnings per share | -2.90 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.50M | 211.68% |
Total assets | 5.60M | 106.69% |
Total liabilities | 2.22M | -34.00% |
Total equity | 3.38M | — |
Shares outstanding | 1.41M | — |
Price to book | 0.74 | — |
Return on assets | -119.36% | — |
Return on capital | -167.93% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.56M | -1.74% |
Cash from operations | -764.09K | 57.59% |
Cash from investing | — | — |
Cash from financing | 112.58K | -92.30% |
Net change in cash | -651.52K | -91.19% |
Free cash flow | 373.37K | 223.16% |
About
Founded
2003
Headquarters
Website
Employees
8
